FDA Authorizes Intradermal Use of Jynneos Vaccine for Monkeypox

[Insiya]

The US Food and Drug Administration (FDA) authorized intradermal administration of the Jynneos vaccine for the treatment of monkeypox. The process, approved specifically for high-risk patients, was passed under the administration's Emergency Use Authorization. It follows the decision on August 4 by the US Department of Health and Human Services to declare monkeypox a public health emergency. Intradermal administration will allow providers to get five doses out of a one-dose vial.

[Olibhiya]

@insiya Monkeypox is a rare but potentially serious disease that requires the full mobilization of all available public health resources to prevent the spread